BERLIN (Reuters) - Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human ...
The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, to those who are at higher risk of severe RSV, the company said Friday ...
The Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial virus (RSV) vaccine for use in at-risk adults over the age of 50. GSK, the vaccine’s maker ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved the first-ever mRNA-1345 vaccine (mRESVIA ...
Geron's CEO said the company anticipates a peak market potential of $1.2 billion in the US and some key EU countries by 2030. In March, by a 12-to-2 margin, the FDA adcomm panel voted in favor of ...
, opens new tab surged more than 20% on Friday, a day after the company gained its first approval from the U.S. Food and Drug Administration for its blood disorder drug. The health regulator's nod ...
Allowing pharmacists to treat minor illnesses could potentially expand healthcare access to more people and save millions of ...
Moderna Inc. has landed its second product approval from the U.S. Food and Drug Administration after its COVID-19 vaccine. The Cambridge drugmaker’s mRNA vaccine for respiratory syncytial virus ...
SPRINGFIELD — The City Council again voted to purchase two firetrucks at a cost of $3.2 million last week. The vote was a formality that put the purchases on the city’s capital improvement ...
Geron (NASDAQ:GERN) shares added ~17% premarket Friday after the U.S. Food and Drug Administration (FDA) approved its lead asset, imetelstat, as a late-line option for a type of blood cancer ...